Gujarat Kidney and Super Speciality Ltd
Acquisition of 51% Stake in Blue Tree Clinics LLC
M&A
▲ Positive Development
MEDIUM RISK
📅 Filed on BSE: 09 Jul 2026, 08:05 PM IST · BSE ID: a5db5293-d154-4a65-93ac-58a78990315f
View Original BSE Filing (PDF)
💡
In Simple Terms
The company bought a 51% share in a Dubai-based medical clinic for Rs 19.83 Crore to expand its operations.
🤖 AI Summary
- Gujarat Kidney and Super Speciality Ltd acquired 51% stake in Blue Tree Clinics LLC for Rs 19,83,64,500/-.
- Blue Tree Clinics LLC, a UAE-based polyclinic, recorded Gross Revenue of 10,538,978 AED in FY 2025.
- The acquisition expands Gujarat Kidney's business into a new geography, UAE, and diversifies its service offerings.
- Consideration of Rs 19,83,64,500/- will be paid in two tranches, with completion targeted within 50 days.
- Mr. (Dr) Paresh Dhoti has been appointed as an Additional- Non Executive- Independent Director effective July 09, 2026.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Cost of Acquisition
Rs 19,83,64,500/-
Percentage of shareholding acquired
51%
Blue Tree Clinics LLC Gross Revenue (FY 2025)
10,538,978 AED
Blue Tree Clinics LLC Net Profit (FY 2025)
31,38,809 AED
🏢 How This Affects the Company
The acquisition expands the company's geographic presence to the UAE and diversifies its medical service offerings to include plastic surgery, laser cosmetic, general dental, and chiropractic services.
Gujarat Kidney will disburse Rs 19,83,64,500/- in cash for the acquisition, impacting its cash position over two tranches within 50 days.
The company will integrate the operations of Blue Tree Clinics LLC, a polyclinic in Dubai, broadening its operational footprint and service portfolio beyond its current Indian operations.
👥 What This Means For Shareholders
✅
Action Required
Shareholders will need to approve a Special Resolution for Variation in Objects of IPO via postal ballot; intimation will be filed separately.
👤
Who Is Affected
All shareholders are affected by the proposed variation in IPO objects, which requires their approval to align with the company's new strategic direction.
🔍
Management Signal
Management is signaling a strategic intent towards international expansion and diversification of healthcare services through acquisitions.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Intimation regarding postal ballot for variation in Objects of IPO.
Completion of the acquisition and payment of consideration tranches within 50 days.
Future financial results reflecting the integration and performance of Blue Tree Clinics LLC.
MEDIUM RISK
Acquisition involves international operations and integration challenges, with a significant cash outflow.
💡 Investor Takeaway
Gujarat Kidney and Super Speciality Ltd acquired a 51% stake in Blue Tree Clinics LLC, UAE, for Rs 19,83,64,500/- cash. Blue Tree Clinics reported Gross Revenue of 10,538,978 AED and Net Profit of 31,38,809 AED in FY 2025, signaling international expansion and service diversification.
⚖️ Strengths & Concerns
✅ Positives
- Expansion into a new international market, UAE, diversifying the company's geographic revenue sources.
- Addition of new medical service lines including plastic surgery and laser cosmetic treatments, broadening its healthcare portfolio.
⚠️ Concerns
- The filing does not provide a breakdown of the purchase price relative to Blue Tree Clinics' net assets or future earnings potential.
- The acquisition involves a significant cash outflow of Rs 19,83,64,500/-, which could impact immediate liquidity.
📅 Company Track Record
Gujarat Kidney and Super Speciality Ltd previously acquired Parekhs Hospital Private Limited for Rs. 77 Crore cash on March 23, 2026, adding Rs. 25.67 Crore annual turnover healthcare operations, demonstrating a pattern of inorganic growth.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What stake did Gujarat Kidney and Super Speciality Ltd acquire in Blue Tree Clinics LLC?
Gujarat Kidney and Super Speciality Ltd acquired a 51% stake in Blue Tree Clinics LLC.
What is the cost of acquisition for Blue Tree Clinics LLC?
The cost of acquisition for 51% stake in Blue Tree Clinics LLC is Rs 19,83,64,500/-, payable in two tranches.
What was the Gross Revenue of Blue Tree Clinics LLC in FY 2025?
Blue Tree Clinics LLC reported a Gross Revenue of 10,538,978 AED for the Financial Year 2025.
What is the main objective of this acquisition by Gujarat Kidney and Super Speciality Ltd?
The objective is to expand the company's existing business into a new geography, UAE, and diversify with services different from those provided in India.
How long will the acquisition process take?
The indicative time period for completion of the acquisition is a maximum of 50 days, with consideration paid in two tranches.
Questions based on this BSE filing only. For information purposes.